Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.
Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.
Theriva生物制品股份下跌，该公司宣布FDA授予VCN-01用于视网膜母细胞瘤治疗的罕见儿科药物认定。
Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.
Theriva生物制品股份下跌，该公司宣布FDA授予VCN-01用于视网膜母细胞瘤治疗的罕见儿科药物认定。
资讯热榜
更新时间